Cerba Research
Aurélia De Pauw, Ph.D., Executive MBA, currently serves as Director of Operations Canada at Cerba Research since September 2023. With extensive experience in the biopharmaceutical sector, Aurélia previously held leadership roles such as Managing Director at Tetra Bio-Pharma and Senior Vice President of Clinical Programs and Medical Affairs. Aurélia's career includes significant contributions to clinical research management, with roles at TALLC Corporation, Keyrus Life Science, and as a freelance Clinical Research Associate. Educationally, Aurélia holds a Ph.D. in Biology from Université de Namur and an Executive MBA from Concordia University, complemented by specialized studies in Oncology and Cancer Biology.
This person is not in any offices
Cerba Research
Cerba Research is the result of the merger of three companies: Barc Lab, Histalim, and Cerba Xpert. Cerba HealthCare owns all three companies and has opted to unite them under one banner. Cerba Research offers quality offers laboratory and diagnostic services, while also harnessing patient data and scientific expertise to help plan and advanceclinical trials. They help global biotech, pharma, and IVD firms to enhance the lives of patients throughout the world by using their worldwide footprint and access to premier regional labs, data, patients, technology, and partnered resources.